Clinical Cancer Research The Future of Cancer Research: Science and Patient Impact
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Kanerva, A.
Right arrow Articles by Curiel, D. T.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Kanerva, A.
Right arrow Articles by Curiel, D. T.
Clinical Cancer Research Vol. 8, 275-280, January 2002
© 2002 American Association for Cancer Research

Experimental Therapeutics, Preclinical Pharmacology

Targeting Adenovirus to the Serotype 3 Receptor Increases Gene Transfer Efficiency to Ovarian Cancer Cells1

Anna Kanerva, Galina V. Mikheeva, Victor Krasnykh, Candace J. Coolidge, John T. Lam, Parameshwar J. Mahasreshti, Shannon D. Barker, Michael Straughn, Mack N. Barnes, Ronald D. Alvarez, Akseli Hemminki and David T. Curiel2

Division of Human Gene Therapy, Departments of Medicine, Pathology, and Surgery and the Gene Therapy Center [A. K., V. K., C. J. C., J. T. L., P. J. M., S. D. B., A. H., D. T. C.], and Division of Gynecology Oncology, Department of Obstetrics and Gynecology [M. S., M. N. B., R. D. A.], University of Alabama at Birmingham, Birmingham, Alabama 35294-3300, and VectorLogics, Inc., Birmingham, Alabama 35294 [G. V. M., V. K.]

Gene delivery efficiency in clinical cancer gene therapy trials with recombinant adenoviruses (Ads) based on serotype 5 (Ad5) has been limited partly because of variable expression of the primary Ad5 receptor, the coxsackie and adenovirus receptor (CAR), on human primary cancer cells. As a means of circumventing CAR deficiency, Ad vectors have been retargeted by creating chimeric fibers possessing knob domains of alternate Ad serotypes. In this study, we have constructed an Ad5-based vector, Ad5/3luc1, with a chimeric fiber protein featuring a knob domain derived from Ad3. This virus is retargeted to the Ad3 receptor and, therefore, has different tissue tropism. A novel knob binding assay was used to measure expression of CAR and the Ad3 receptor. Further, to evaluate the correlation of receptor expression and infectivity by Ad, a panel of ovarian cancer cell lines and purified primary cancer cells were infected with Ad5luc1 and Ad5/3luc1 at 50, 200, and 1000 viral particles/cell. Our results confirm that Ad5/3luc1 is retargeted to the Ad3 receptor. Furthermore, the Ad3 receptor is present at higher levels than CAR on ovarian adenocarcinoma cells. Also, the amount of binding to primary receptor appears to be the major factor determining the efficiency of transgene expression. The Ad5/3 chimera displays enhanced infectivity for ovarian cancer cell lines and purified primary tumor cells, which could translate into increased efficacy in clinical trials.




This article has been cited by other articles:


Home page
 Cancer Res.Home page
G. J. Bauerschmitz, T. Ranki, L. Kangasniemi, C. Ribacka, M. Eriksson, M. Porten, I. Herrmann, A. Ristimaki, P. Virkkunen, M. Tarkkanen, et al.
Tissue-Specific Promoters Active in CD44+CD24-/low Breast Cancer Cells
Cancer Res., July 15, 2008; 68(14): 5533 - 5539.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Cancer Res.Home page
Y. Tsuruta, L. Pereboeva, M. Breidenbach, D. T. Rein, M. Wang, R. D. Alvarez, G. P. Siegal, P. Dent, P. B. Fisher, and D. T. Curiel
A Fiber-Modified Mesothelin Promoter-Based Conditionally Replicating Adenovirus for Treatment of Ovarian Cancer
Clin. Cancer Res., June 1, 2008; 14(11): 3582 - 3588.
[Abstract] [Full Text] [PDF]

Home page
 Molecular Cancer TherapeuticsHome page
K. Guse, T. Ranki, M. Ala-Opas, P. Bono, M. Sarkioja, M. Rajecki, A. Kanerva, T. Hakkarainen, and A. Hemminki
Treatment of metastatic renal cancer with capsid-modified oncolytic adenoviruses
Mol. Cancer Ther., October 1, 2007; 6(10): 2728 - 2736.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Cancer Res.Home page
Y. Tsuruta, L. Pereboeva, J. N. Glasgow, D. T. Rein, Y. Kawakami, R. D. Alvarez, R. P. Rocconi, G. P. Siegal, P. Dent, P. B. Fisher, et al.
A Mosaic Fiber Adenovirus Serotype 5 Vector Containing Reovirus {sigma}1 and Adenovirus Serotype 3 Knob Fibers Increases Transduction in an Ovarian Cancer Ex vivo System via a Coxsackie and Adenovirus Receptor Independent Pathway
Clin. Cancer Res., May 1, 2007; 13(9): 2777 - 2783.
[Abstract] [Full Text] [PDF]

Home page
 Molecular Cancer TherapeuticsHome page
M. Rajecki, A. Kanerva, U.-H. Stenman, M. Tenhunen, L. Kangasniemi, M. Sarkioja, M. Y. Ala-Opas, H. Alfthan, A. Sankila, E. Rintala, et al.
Treatment of prostate cancer with Ad5/3{Delta}24hCG allows non-invasive detection of the magnitude and persistence of virus replication in vivo
Mol. Cancer Ther., February 1, 2007; 6(2): 742 - 751.
[Abstract] [Full Text] [PDF]

Home page
 J. Virol.Home page
S. Tuve, H. Wang, C. Ware, Y. Liu, A. Gaggar, K. Bernt, D. Shayakhmetov, Z. Li, R. Strauss, D. Stone, et al.
A New Group B Adenovirus Receptor Is Expressed at High Levels on Human Stem and Tumor Cells
J. Virol., December 15, 2006; 80(24): 12109 - 12120.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Cancer Res.Home page
L. Kangasniemi, T. Kiviluoto, A. Kanerva, M. Raki, T. Ranki, M. Sarkioja, H. Wu, F. Marini, K. Hockerstedt, H. Isoniemi, et al.
Infectivity-Enhanced Adenoviruses Deliver Efficacy in Clinical Samples and Orthotopic Models of Disseminated Gastric Cancer.
Clin. Cancer Res., May 15, 2006; 12(10): 3137 - 3144.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Cancer Res.Home page
J. M. Mathis, P. L. Stewart, Z. B. Zhu, and D. T. Curiel
Advanced Generation Adenoviral Virotherapy Agents Embody Enhanced Potency Based upon CAR-Independent Tropism.
Clin. Cancer Res., May 1, 2006; 12(9): 2651 - 2656.
[Full Text] [PDF]

Home page
 Molecular Cancer TherapeuticsHome page
S. Komarova, Y. Kawakami, M. A. Stoff-Khalili, D. T. Curiel, and L. Pereboeva
Mesenchymal progenitor cells as cellular vehicles for delivery of oncolytic adenoviruses.
Mol. Cancer Ther., March 1, 2006; 5(3): 755 - 766.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Cancer Res.Home page
D. T. Rein, M. Breidenbach, T. O. Kirby, T. Han, G. P. Siegal, G. J. Bauerschmitz, M. Wang, D. M. Nettelbeck, Y. Tsuruta, M. Yamamoto, et al.
A Fiber-Modified, Secretory Leukoprotease Inhibitor Promoter-Based Conditionally Replicating Adenovirus for Treatment of Ovarian Cancer
Clin. Cancer Res., February 1, 2005; 11(3): 1327 - 1335.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Cancer Res.Home page
T. O. Kirby, A. Rivera, D. Rein, M. Wang, I. Ulasov, M. Breidenbach, M. Kataram, J. L. Contreras, C. Krumdieck, M. Yamamoto, et al.
A Novel Ex vivo Model System for Evaluation of Conditionally Replicative Adenoviruses Therapeutic Efficacy and Toxicity
Clin. Cancer Res., December 15, 2004; 10(24): 8697 - 8703.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
J. Davydova, L. P. Le, T. Gavrikova, M. Wang, V. Krasnykh, and M. Yamamoto
Infectivity-Enhanced Cyclooxygenase-2-Based Conditionally Replicative Adenoviruses for Esophageal Adenocarcinoma Treatment
Cancer Res., June 15, 2004; 64(12): 4319 - 4327.
[Abstract] [Full Text] [PDF]

Home page
 IOVSHome page
J. N. Mallam, M. Y. Hurwitz, T. Mahoney, P. Chevez-Barrios, and R. L. Hurwitz
Efficient Gene Transfer into Retinal Cells Using Adenoviral Vectors: Dependence on Receptor Expression
Invest. Ophthalmol. Vis. Sci., June 1, 2004; 45(6): 1680 - 1687.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Cancer Res.Home page
M. Qin, S. Chen, T. Yu, B. Escuadro, S. Sharma, and R. K. Batra
Coxsackievirus Adenovirus Receptor Expression Predicts the Efficiency of Adenoviral Gene Transfer into Non-Small Cell Lung Cancer Xenografts
Clin. Cancer Res., October 15, 2003; 9(13): 4992 - 4999.
[Abstract] [Full Text] [PDF]

Home page
 Stem CellsHome page
L. Pereboeva, S. Komarova, G. Mikheeva, V. Krasnykh, and D.T. Curiel
Approaches to Utilize Mesenchymal Progenitor Cells as Cellular Vehicles
Stem Cells, July 1, 2003; 21(4): 389 - 404.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
Y. Kawakami, H. Li, J. T. Lam, V. Krasnykh, D. T. Curiel, and J. L. Blackwell
Substitution of the Adenovirus Serotype 5 Knob with a Serotype 3 Knob Enhances Multiple Steps in Virus Replication
Cancer Res., March 15, 2003; 63(6): 1262 - 1269.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Cancer Res.Home page
T. Hakkarainen, A. Hemminki, A. V. Pereboev, S. D. Barker, C. K. Asiedu, T. V. Strong, A. Kanerva, J. Wahlfors, and D. T. Curiel
CD40 Is Expressed on Ovarian Cancer Cells and Can Be Utilized for Targeting Adenoviruses
Clin. Cancer Res., February 1, 2003; 9(2): 619 - 624.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
Y. S. Haviv, J. L. Blackwell, A. Kanerva, P. Nagi, V. Krasnykh, I. Dmitriev, M. Wang, S. Naito, X. Lei, A. Hemminki, et al.
Adenoviral Gene Therapy for Renal Cancer Requires Retargeting to Alternative Cellular Receptors
Cancer Res., August 1, 2002; 62(15): 4273 - 4281.
[Abstract] [Full Text] [PDF]

Home page
 JNCI J Natl Cancer InstHome page
W. Russell
Adenovirus Gene Therapy for Ovarian Cancer
J Natl Cancer Inst, May 15, 2002; 94(10): 706 - 707.
[Full Text] [PDF]

Home page
 JNCI J Natl Cancer InstHome page
A. Hemminki, K. R. Zinn, B. Liu, T. R. Chaudhuri, R. A. Desmond, B. E. Rogers, M. N. Barnes, R. D. Alvarez, and D. T. Curiel
In Vivo Molecular Chemotherapy and Noninvasive Imaging With an Infectivity-Enhanced Adenovirus
J Natl Cancer Inst, May 15, 2002; 94(10): 741 - 749.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 2002 by the American Association for Cancer Research.